Skip to main content

Table 2 Characteristics of patients meeting ACR and/or AECG criteria for Sjögren’s syndrome

From: Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies

  Patients fulfilling
  Both sets ACR set only AECG set only Neither set
  (n = 27) (n = 8) (n = 15) (n = 55)
Age (years) 60.7 ± 11.7 46.6 ± 15.8 59.3 ± 11.1 56.4 ± 14.5
Symptom duration (years) 9.5 ± 7.4 2.9 ± 2.4 4.7 ± 4.3 6.4 ± 5.7
Female 25 (92.6) 8 (100) 14 (93.3) 52 (94.5)
Xerophthalmia 26 (96.3) 6 (75.0) 14 (93.3) 50 (90.9)
Xerostomia 27 (100) 6 (75.0) 15 (100) 51 (92.7)
Salivary flow ≤0.1 ml/minute 18 (66.7) 0 (0) 10 (66.7) 16 (29.1)
Schirmer’s test ≤5 mm/5 minutes 22 (81.5) 1 (12.5) 12 (80.0) 13 (23.6)
OSS ≥3 24 (88.9) 6 (75.0) 0 (0) 19 (34.5)
Anti-SSA or anti-SSB positivity 18 (66.7) 4 (50.0) 4 (26.7) 1 (1.8)
ANA ≥1:320 25 (92.6) 5 (62.5) 8 (53.3) 18 (32.7)
RF positivity 14 (51.9) 4 (50.0) 1 (6.7) 6 (10.9)
Anti-SSA/SSB or RF plus ANA ≥1:320 21 (77.8) 4 (50.0) 4 (26.7) 1 (1.8)
Focus score ≥1 24 (88.9) 7 (87.5) 11 (73.3) 6 (10.9)
  1. Data presented as mean ± standard deviation or number (%). Xerophthalmia and xerostomia referred to subjective complaints from the patients. ACR, American College of Rheumatology; AECG, American–European Consensus Group; OSS, ocular staining score; ANA, antinuclear antibody; RF, rheumatoid factor.